These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 10382082

  • 1. Cycle control with oral contraceptives containing 20 micrograms of ethinyl estradiol. A multicenter, randomized comparison of levonorgestrel/ethinyl estradiol (100 micrograms/20 micrograms) and norethindrone/ethinyl estradiol (1000 micrograms/20 micrograms).
    DelConte A, Loffer F, Grubb GS.
    Contraception; 1999 Mar; 59(3):187-93. PubMed ID: 10382082
    [Abstract] [Full Text] [Related]

  • 2. A comparison of cycle control with monophasic levonorgestrel/ethinylestradiol 100 micrograms/20 micrograms versus triphasic norethindrone/ethinylestradiol 500-750-1000 micrograms/35 micrograms: a multicenter, randomized, open-label study.
    Chavez A, DelConte A.
    Eur J Contracept Reprod Health Care; 1999 Jun; 4(2):75-83. PubMed ID: 10427482
    [Abstract] [Full Text] [Related]

  • 3. A clinical comparison of two triphasic oral contraceptives with levonorgestrel or norethindrone: a prospective, randomized, single-blind study.
    Masson S, Franssen E, Hilditch JR, Powell MG.
    Contraception; 1993 Jan; 47(1):43-54. PubMed ID: 8436001
    [Abstract] [Full Text] [Related]

  • 4. Effect of low-dose oral contraceptives on androgenic markers and acne.
    Thorneycroft IH, Stanczyk FZ, Bradshaw KD, Ballagh SA, Nichols M, Weber ME.
    Contraception; 1999 Nov; 60(5):255-62. PubMed ID: 10717776
    [Abstract] [Full Text] [Related]

  • 5. Clinical comparison of triphasic norgestimate/35 micrograms ethinyl estradiol and monophasic norethindrone acetate/20 micrograms ethinyl estradiol. Cycle control, lipid effects, and user satisfaction.
    Sulak P, Lippman J, Siu C, Massaro J, Godwin A.
    Contraception; 1999 Mar; 59(3):161-6. PubMed ID: 10382078
    [Abstract] [Full Text] [Related]

  • 6. Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 microg ethinylestradiol/100 microg levonorgestrel and 20 microg ethinylestradiol/500 microg norethisterone.
    Endrikat J, Hite R, Bannemerschult R, Gerlinger C, Schmidt W.
    Contraception; 2001 Jul; 64(1):3-10. PubMed ID: 11535206
    [Abstract] [Full Text] [Related]

  • 7. A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 micrograms ethinyl estradiol and 100 micrograms levonorgestrel over six treatment cycles.
    Bannemerschult R, Hanker JP, Wünsch C, Fox P, Albring M, Brill K.
    Contraception; 1997 Nov; 56(5):285-90. PubMed ID: 9437556
    [Abstract] [Full Text] [Related]

  • 8. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
    Ahrendt HJ, Makalová D, Parke S, Mellinger U, Mansour D.
    Contraception; 2009 Nov; 80(5):436-44. PubMed ID: 19835717
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of a new triphasic oral contraceptive in private practice.
    Ellsworth HS, Ayerst RI, Harris JW, Stone RA, Anderson AE, Jones TL, Curtis MK.
    Contraception; 1986 Nov; 34(5):435-42. PubMed ID: 3102161
    [Abstract] [Full Text] [Related]

  • 10. A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 microg levonorgestrel with 20 microg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol.
    Reisman H, Martin D, Gast MJ.
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):45-52. PubMed ID: 10561675
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study.
    Endrikat J, Düsterberg B, Ruebig A, Gerlinger C, Strowitzki T.
    Contraception; 1999 Nov; 60(5):269-74. PubMed ID: 10717778
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Scheduled and unscheduled bleeding patterns with two combined hormonal contraceptives: application of new recommendations for standardization.
    Hampton RM, Fisher AC, Pagano S, LaGuardia KD.
    Fertil Steril; 2009 Aug; 92(2):434-40. PubMed ID: 18930189
    [Abstract] [Full Text] [Related]

  • 15. Cycle control, tolerability, and satisfaction among women switching from 30-35 microg ethinyl estradiol-containing oral contraceptives to the triphasic norgestimate/25 microg ethinyl estradiol-containing oral contraceptive Ortho Tri-Cyclen LO.
    Poindexter AN, Burkman R, Fisher AC, LaGuardia KD.
    Int J Fertil Womens Med; 2003 Aug; 48(4):163-72. PubMed ID: 13677549
    [Abstract] [Full Text] [Related]

  • 16. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M, Røde A, Westergaard J.
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [Abstract] [Full Text] [Related]

  • 17. Clinical comparative study of oral contraceptives containing 30 microg ethinylestradiol/150 microg levonorgestrel, and 35 microg ethinylestradiol/250 microg norgestimate in Thai women.
    Tantbirojn P, Taneepanichskul S.
    Contraception; 2002 Dec; 66(6):401-5. PubMed ID: 12499031
    [Abstract] [Full Text] [Related]

  • 18. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial.
    Teichmann A, Apter D, Emerich J, Greven K, Klasa-Mazurkiewicz D, Melis GB, Spaczynski M, Grubb GS, Constantine GD, Spielmann D.
    Contraception; 2009 Dec; 80(6):504-11. PubMed ID: 19913143
    [Abstract] [Full Text] [Related]

  • 19. Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy women: a randomized, single-blind, parallel-group, multicentre study.
    Kelly S, Davies E, Fearns S, McKinnon C, Carter R, Gerlinger C, Smithers A.
    Clin Drug Investig; 2010 Dec; 30(5):325-36. PubMed ID: 20384388
    [Abstract] [Full Text] [Related]

  • 20. Oestrogen treatment for increased bleeding in Norplant users: preliminary results.
    Witjaksono J, Lau TM, Affandi B, Rogers PA.
    Hum Reprod; 1996 Oct; 11 Suppl 2():109-14. PubMed ID: 8982752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.